Interestingly, PSPC strikingly reversed these pathological liver injuries and NAFLD-related parameters in HFD-treated mice (body weights: 45.4 ± 2.13 g; ALT: 35.79 ± 6.55 U/L; TG: 19.17 ± 3.11 mg/g protein) (Fig. 1). The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.